Patent Protection and Bypass Continuation Applications: Evaluating Benefits and Risks, Navigating Priority

Dr. Landau is a seasoned Patent attorney with 18+ years of legal experience and doctoral level training in environmental/industrial microbiology. As a Shareholder in the Firm’s Intellectual Property Group, he focuses his practice on patent drafting, patent prosecution, managing international patent portfolios, providing legal analysis and opinions, and brand protection and enforcement. Dedicated to intellectual property law and the advancement of biological science, Dr. Landau is active in the biotechnology industry, serving as a board member of BIO Alabama, former Chair of the AIPLA Biotechnology Committee, and an Adjunct Professor of Law at Cumberland School of Law.

With more than 25 years of experience in biotechnology patent prosecution and counseling, Ms. McNeill offers intellectual property strategy, new application preparation, patent prosecution (US and foreign), preparation and negotiation of IP transactions, USPTO contentious practice, and the full scope of counseling services to clients of various sizes. She has earned a reputation for excellence in her field, having been recognized as an IP Star by both Managing Intellectual Property and LMG Life Sciences and ranked with an AV Preeminent® Peer Review Rating from Martindale-Hubbell. ® Ms. McNeill  has worked with biotech start-ups, research foundations, universities, and pharmaceutical companies, ranging from early-stage to publicly-traded companies. She has managed and directed the US and international patent portfolios for US clients and has overseen the US patent portfolio for international clients in Europe and Asia. Ms. McNeill has also expertly resolved material errors made by others in transactions with the US Patent and Trademark Office, in applications under the PCT, or in foreign patent prosecution, including filing errors and errors in the payment of maintenance or annuity fees. She also has experience in litigation and USPTO contentious proceedings. 

Ms. Mueller is an experienced intellectual property attorney specializing in patent, trademark, and copyright law. For over twenty-five years, she has provided strategic counsel on complex patent issues to clients in the pharmaceutical, biopharmaceutical, biotechnology, and chemistry sectors. With an in-depth knowledge of patent prosecution, opposition, and global portfolio management, Ms. Mueller advises clients on the protection, freedom to operate, and validity of blockbuster drugs. Her expertise extends to small molecules, biologics, drug delivery methods, diagnostics, personalized medicine, renewable chemistry, and agricultural sciences. Ms. Mueller's background in chemistry and biology enables her to navigate diverse regulatory matters, including U.S. FDA approvals. She works closely with in-house legal departments of global pharmaceutical firms, providing training and problem-solving strategies. A thought leader in pharmaceutical patent law, Ms. Mueller frequently speaks to legal and industry groups and publishes widely. She authors the blog “Patent Panorama,” offering insights on patent law developments in the life sciences industry globally.